208 related articles for article (PubMed ID: 12928788)
1. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress.
Mantovani G; Macciò A; Madeddu C; Mura L; Gramignano G; Lusso MR; Massa E; Mocci M; Serpe R
J Mol Med (Berl); 2003 Oct; 81(10):664-73. PubMed ID: 12928788
[TBL] [Abstract][Full Text] [Related]
2. Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity.
Mantovani G; Macciò A; Madeddu C; Serpe R; Massa E; Gramignano G; Lusso MR; Curreli N; Rinaldi A
J Exp Ther Oncol; 2004 Apr; 4(1):69-78. PubMed ID: 15255293
[TBL] [Abstract][Full Text] [Related]
3. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine.
Mantovani G; Macciò A; Melis G; Mura L; Massa E; Mudu MC
Int J Cancer; 2000 Jun; 86(6):842-7. PubMed ID: 10842199
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species, antioxidant mechanisms, and serum cytokine levels in cancer patients: impact of an antioxidant treatment.
Mantovani G; Macciò A; Madeddu C; Mura L; Massa E; Gramignano G; Lusso MR; Murgia V; Camboni P; Ferreli L
J Environ Pathol Toxicol Oncol; 2003; 22(1):17-28. PubMed ID: 12678402
[TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status.
Mantovani G; Macciò A; Madeddu C; Mura L; Gramignano G; Lusso MR; Mulas C; Mudu MC; Murgia V; Camboni P; Massa E; Ferreli L; Contu P; Rinaldi A; Sanjust E; Atzei D; Elsener B
Int J Cancer; 2002 Mar; 98(1):84-91. PubMed ID: 11857390
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters.
Mantovani G; Madeddu C; Gramignano G; Lusso MR; Mocci M; Massa E; Ferreli L; Astara G; Macciò A; Serpe R
J Exp Ther Oncol; 2003; 3(4):205-19. PubMed ID: 14567291
[TBL] [Abstract][Full Text] [Related]
7. The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression.
Mantovani G; Macciò A; Madeddu C; Mura L; Gramignano G; Lusso MR; Murgia V; Camboni P; Ferreli L; Mocci M; Massa E
Free Radic Res; 2003 Feb; 37(2):213-23. PubMed ID: 12653210
[TBL] [Abstract][Full Text] [Related]
8. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment.
Mantovani G; Madeddu C; Macciò A; Gramignano G; Lusso MR; Massa E; Astara G; Serpe R
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1651-9. PubMed ID: 15466983
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy.
Mantovani G; Maccio A; Madeddu C; Massa E; Mudu MC; Mulas C; Gramignano G; Massidda S; Murgia V; Lusso MR; Mura L
Int J Oncol; 2001 Feb; 18(2):383-91. PubMed ID: 11172608
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment.
Mantovani G; Macciò A; Madeddu C; Mura L; Massa E; Gramignano G; Lusso MR; Murgia V; Camboni P; Ferreli L
J Cell Mol Med; 2002; 6(4):570-82. PubMed ID: 12611641
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites.
Mantovani G; Macciò A; Mura L; Massa E; Mudu MC; Mulas C; Lusso MR; Madeddu C; Dessì A
J Mol Med (Berl); 2000; 78(10):554-61. PubMed ID: 11199328
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy.
Mantovani G; Macciò A; Madeddu C; Mulas C; Massa E; Astara G; Ferreli L; Mudu MC; Gramignano G; Murgia V; Lusso MR; Mocci M; Cardia A; Mura L
Oncol Rep; 2002; 9(4):887-96. PubMed ID: 12066227
[TBL] [Abstract][Full Text] [Related]
13. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
Mantovani G; Macciò A; Madeddu C; Gramignano G; Lusso MR; Serpe R; Massa E; Astara G; Deiana L
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1030-4. PubMed ID: 16702388
[TBL] [Abstract][Full Text] [Related]
14. Centella asiatica modulates cancer cachexia associated inflammatory cytokines and cell death in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC's).
Naidoo DB; Chuturgoon AA; Phulukdaree A; Guruprasad KP; Satyamoorthy K; Sewram V
BMC Complement Altern Med; 2017 Aug; 17(1):377. PubMed ID: 28764778
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients.
Fortunati N; Manti R; Birocco N; Pugliese M; Brignardello E; Ciuffreda L; Catalano MG; Aragno M; Boccuzzi G
Oncol Rep; 2007 Dec; 18(6):1521-7. PubMed ID: 17982639
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life.
Macciò A; Madeddu C; Gramignano G; Mulas C; Floris C; Sanna E; Cau MC; Panzone F; Mantovani G
Gynecol Oncol; 2012 Mar; 124(3):417-25. PubMed ID: 22198049
[TBL] [Abstract][Full Text] [Related]
17. Ascorbic acid, alpha-tocopherol, and beta-carotene reduce oxidative stress and proinflammatory cytokines in mononuclear cells of Alzheimer's disease patients.
de Oliveira BF; Veloso CA; Nogueira-Machado JA; de Moraes EN; dos Santos RR; Cintra MT; Chaves MM
Nutr Neurosci; 2012 Nov; 15(6):244-51. PubMed ID: 22710805
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer.
Dülger H; Alici S; Sekeroğlu MR; Erkog R; Ozbek H; Noyan T; Yavuz M
Int J Clin Pract; 2004 Jun; 58(6):545-9. PubMed ID: 15311551
[TBL] [Abstract][Full Text] [Related]
19. The role of oxidative imbalance in progression to AIDS: effect of the thiol supplier N-acetylcysteine.
Malorni W; Rivabene R; Lucia BM; Ferrara R; Mazzone AM; Cauda R; Paganelli R
AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1589-96. PubMed ID: 9840292
[TBL] [Abstract][Full Text] [Related]
20. Comparative effect of fucoxanthin and vitamin C on oxidative and functional parameters of human lymphocytes.
Molina N; Morandi AC; Bolin AP; Otton R
Int Immunopharmacol; 2014 Sep; 22(1):41-50. PubMed ID: 24975831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
